Cargando…
Antineoplastics: Pancytopenia and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546935/ http://dx.doi.org/10.1007/s40278-020-84279-y |
Ejemplares similares
-
Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022) -
Moxifloxacin/umifenovir: Pancytopenia and off label use: case report
Publicado: (2021) -
Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020) -
Ciclesonide/favipiravir/lopinavir/ritonavir: Off-label use, pancytopenia and liver dysfunction: case report
Publicado: (2021) -
Antineoplastics/antiretrovirals: COVID-19, and diarrhoea due to off-label use: 3 case reports
Publicado: (2020)